EUVIMEDEUVIMED entdecken
Studienprotokoll

Neoadjuvant Cytoreductive Treatment of Regionally Advanced Melanoma With BRAF/MEK Inhibition: Study Protocol of the REDUCTOR (Cytoreductive Treatment of Dabrafenib Combined With Trametinib to Allow Complete Surgical Resection in Patients With BRAF Mutated, Prior Unresectable Stage III or IV Melanoma) Trial

Max F. Madu, E.A. Lisette Rozeman, Jos A. van der Hage, Michel W.J.M. Wouters, W. Martin C. Klop, J.V. Hans van Thienen, Christian U. Blank, John B.A.G. Haanen, Alexander C.J. van Akkooi

Clinical Skin Cancer · 2016

DOI: 10.1016/j.clsc.2016.11.006 ↗

Kurz gefasst

Studienprotokoll in der Zeitschrift Clinical Skin Cancer, 2016. Verfasst von Max F. Madu und 8 weiteren Autor:innen. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 10 Literaturangaben.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Zitieren

APA

Madu, M. F., Rozeman, E. L., Hage, J. A. V. D., Wouters, M. W., Klop, W. M. C., Thienen, J. H. V., Blank, C. U., Haanen, J. B., & Akkooi, A. C. V. (2016). Neoadjuvant Cytoreductive Treatment of Regionally Advanced Melanoma With BRAF/MEK Inhibition: Study Protocol of the REDUCTOR (Cytoreductive Treatment of Dabrafenib Combined With Trametinib to Allow Complete Surgical Resection in Patients With BRAF Mutated, Prior Unresectable Stage III or IV Melanoma) Trial. Clinical Skin Cancer. https://doi.org/10.1016/j.clsc.2016.11.006

Vancouver

Madu MF, Rozeman EL, Hage JAVD, Wouters MW, Klop WMC, Thienen JHV, et al. Neoadjuvant Cytoreductive Treatment of Regionally Advanced Melanoma With BRAF/MEK Inhibition: Study Protocol of the REDUCTOR (Cytoreductive Treatment of Dabrafenib Combined With Trametinib to Allow Complete Surgical Resection in Patients With BRAF Mutated, Prior Unresectable Stage III or IV Melanoma) Trial. Clinical Skin Cancer. 2016. doi:10.1016/j.clsc.2016.11.006

BibTeX
@article{Madu2016,
  author = {Madu, Max F. and Rozeman, E.A. Lisette and Hage, Jos A. van der and Wouters, Michel W.J.M. and Klop, W. Martin C. and Thienen, J.V. Hans van and Blank, Christian U. and Haanen, John B.A.G. and Akkooi, Alexander C.J. van},
  title = {Neoadjuvant Cytoreductive Treatment of Regionally Advanced Melanoma With BRAF/MEK Inhibition: Study Protocol of the REDUCTOR (Cytoreductive Treatment of Dabrafenib Combined With Trametinib to Allow Complete Surgical Resection in Patients With BRAF Mutated, Prior Unresectable Stage III or IV Melanoma) Trial},
  journal = {Clinical Skin Cancer},
  year = {2016},
  doi = {10.1016/j.clsc.2016.11.006}
}
Kostenlos starten →